Naturland Holding Zrt (BUD:NATURLAND) 1-Year Sharpe Ratio: 0.66 (As of Jul. 11, 2026)


BUD:NATURLAND Naturland Holding Zrt BUD:NATURLAND
61 GF Score
Price Ft2,740.00
GF Value Ft2,888.55
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Naturland Holding Zrt 1-Year Sharpe Ratio?

Naturland Holding Zrt BUD:NATURLAND 61 1-Year Sharpe Ratio is 0.66 as of Jul. 11, 2026. GuruFocus rates BUD:NATURLAND with a GF Score™ of 61/100 and a GF Value™ of Ft2,888.55 (Fairly Valued). The stock has 5 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-11), Naturland Holding Zrt's 1-Year Sharpe Ratio is 0.66.

Naturland Holding Zrt  (BUD:NATURLAND) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Naturland Holding Zrt 1-Year Sharpe Ratio Related Terms

BUD:NATURLAND vs ZTS, UTHR, VTRS: 1-Year Sharpe Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Naturland Holding Zrt's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Naturland Holding Zrt 1-Year Sharpe Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Naturland Holding Zrt's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Naturland Holding Zrt's 1-Year Sharpe Ratio falls into.


BUD:NATURLAND
61GF Score
Naturland Holding Zrt BUD:NATURLAND
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Naturland Holding Zrt 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.66 mean?
Naturland Holding Zrt (BUD:NATURLAND) has a 1-Year Sharpe Ratio of 0.66 as of Jul. 11, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Naturland Holding Zrt and its competitors.
Is Naturland Holding Zrt's 1-Year Sharpe Ratio too high?
Naturland Holding Zrt's current 1-Year Sharpe Ratio is 0.66. Overall, Naturland Holding Zrt has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Naturland Holding Zrt's 1-Year Sharpe Ratio compare to ZTS and UTHR?
Naturland Holding Zrt's 1-Year Sharpe Ratio of 0.66 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Drug Manufacturers company?
A good 1-Year Sharpe Ratio depends on the Drug Manufacturers industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Naturland Holding Zrt and its competitors. Naturland Holding Zrt's current 1-Year Sharpe Ratio is 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturland Holding Zrt stock overvalued right now?
Based on GuruFocus' analysis, Naturland Holding Zrt (BUD:NATURLAND) is currently considered Fairly Valued. The stock's GF Value™ is Ft2,888.55, compared to a current price of Ft2,740.00 — trading 5.1% below its estimated fair value. The current 1-Year Sharpe Ratio is 0.66. Naturland Holding Zrt's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Naturland Holding Zrt (BUD:NATURLAND), the current 1-Year Sharpe Ratio is 0.66 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naturland Holding Zrt (BUD:NATURLAND) Overvalued in 2026?

Based on GuruFocus' analysis, Naturland Holding Zrt stock appears to be undervalued. The current stock price of Ft2,740.00 is trading 5.1% below its estimated GF Value™ of Ft2,888.55. GuruFocus considers Naturland Holding Zrt to be Fairly Valued.

Key valuation signals for BUD:NATURLAND:

  • 1-Year Sharpe Ratio: 0.66
  • GF Value™: Ft2,888.55 vs. price of Ft2,740.00 (5.1% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the BUD:NATURLAND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Naturland Holding Zrt Business Description

Address Csillagvirag utca 8, Budapest, HUN, 1106
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.
61GF Score

Get the complete analysis for BUD:NATURLAND

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft2,740.00
Price
Ft2,888.55
GF Value